Paramedics transport a 68-year-old male to the emergency room due to progressive, profound weakness over the past 24 hours. The patient has a background of ischemic cardiomyopathy and stage IV chronic kidney disease. Current outpatient medications comprise lisinopril, spironolactone, and carvedilol. Initial triage vital signs demonstrate a pulse of 42/min and a blood pressure of 105/60 mmHg. A 12-lead electrocardiogram displays a sine wave pattern with widened QRS complexes and prominently peaked T waves. A point-of-care basic metabolic panel is notable for a potassium concentration of 8.2 mEq/L. Arrange the following pharmacologic therapies in the correct chronological order for the acute management of this presentation.
- 1Intravenous calcium gluconate
- 2Intravenous regular insulin and 50% dextrose
- 3Oral sodium zirconium cyclosilicate
Answer
The correct sequence of administration is intravenous calcium gluconate, followed by intravenous regular insulin and 50% dextrose, and finally oral sodium zirconium cyclosilicate.
The correct sequence prioritizes immediate life-saving stabilization over slower, definitive treatments. Intravenous calcium gluconate must be given immediately because it stabilizes the cardiac membrane within 1 to 3 minutes, preventing ventricular fibrillation. Once the heart is stabilized, intravenous regular insulin (with dextrose to prevent hypoglycemia) is given to rapidly shift potassium into cells, which takes 15 to 30 minutes. Finally, oral sodium zirconium cyclosilicate is administered to bind potassium in the gut for permanent excretion from the body, a process that takes hours to days.
Step-by-Step Solution
Key Concept
The step-wise acute management of severe hyperkalemia with electrocardiographic changes requires immediate myocardial stabilization (calcium), followed by intracellular shifting (insulin/dextrose), and finally total body elimination (cation exchangers or dialysis).